Please login to the form below

Not currently logged in
Email:
Password:

Sophia Genetics appoints CFO

Valentin Matillon joins firm from the Hobart Group

Data-driven medicine firm Sophia Genetics has appointed its new chief financial officer in the form of Valentin Matillon.

He brings over two decades worth of experience in senior financial management positions to the group, holding roles in technology organisations including SITA, Hewlett-Packard and Electronic Arts.

He said: “Our ground breaking technology and approach are revolutionising the healthcare field, improving the prognosis of patients worldwide and I look forward to supporting the company through its journey of growth and development.”

Matillon joins Sophia Genetics from the Hobart Group, where he served as senior director of finance.

His new role will see him take responsibility for the company’s finance and accounting functions.

Jurgi Camblong, chief executive officer and co-founder of Sophia Genetics, said: “Matillon’s track record in transforming finance functions and supporting new acquisitions, along with his pragmatic and results-driven approach, make him a natural fit for the fast-paced culture of Sophia Genetics.”

19th January 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics